Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 2;20(19):4888.
doi: 10.3390/ijms20194888.

Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases

Affiliations
Review

Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases

Francisco Javier Ruiz-Ojeda et al. Int J Mol Sci. .

Abstract

The extracellular matrix (ECM) is a network of different proteins and proteoglycans that controls differentiation, migration, repair, survival, and development, and it seems that its remodeling is required for healthy adipose tissue expansion. Obesity drives an excessive lipid accumulation in adipocytes, which provokes immune cells infiltration, fibrosis (an excess of deposition of ECM components such as collagens, elastin, and fibronectin) and inflammation, considered a consequence of local hypoxia, and ultimately insulin resistance. To understand the mechanism of this process is a challenge to treat the metabolic diseases. This review is focused at identifying the putative role of ECM in adipose tissue, describing its structure and components, its main tissue receptors, and how it is affected in obesity, and subsequently the importance of an appropriate ECM remodeling in adipose tissue expansion to prevent metabolic diseases.

Keywords: adipose tissue; extracellular matrix; insulin resistance; obesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
ECM remodeling is linked to obesity and IR in adipose tissue. Abbreviations: AKT: protein kinase B; EGF: epidermal growth factor; EGFR: epidermal growth factor receptor; ERK: extracellular-signal-regulated kinase; FGF: fibroblast growth factor; FGFR: fibroblast growth factor receptor; GLUT4: glucose transporter type 4; ILK: integrin-linked kinase; IR: insulin receptor; IRS1: Insulin receptor substrate 1; MAPK: mitogen-activated protein kinases; mTOR: mammalian target of Rapamycin; PI3K: phosphatidylinositol 3-kinase; RGD: Arg–Gly–Asp peptide; SOS: Son of Sevenless; Src: Proto-oncogene tyrosine-protein kinase.

Similar articles

Cited by

References

    1. The GBD 2015 Obesity Collaborators. Afshin A., Forouzanfar M.H., Reitsma M.B., Sur P., Estep K., Lee A., Marczak L., Mokdad A.H., Moradi-Lakeh M., et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N. Engl. J. Med. 2017;377:13–27. - PMC - PubMed
    1. GBD 2015 Eastern Mediterranean Region Obesity Collaborators Burden of obesity in the Eastern Mediterranean Region: Findings from the Global Burden of Disease 2015 study. Int. J. Public Health. 2018;63:165–176. doi: 10.1007/s00038-017-1002-5. - DOI - PMC - PubMed
    1. Mokdad A.H., Forouzanfar M.H., Daoud F., El Bcheraoui C., Moradi-Lakeh M., Khalil I., Afshin A., Tuffaha M., Charara R., Barber R.M., et al. Health in times of uncertainty in the eastern Mediterranean region, 1990–2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet Glob. Health. 2016;4:e704–e713. doi: 10.1016/S2214-109X(16)30168-1. - DOI - PMC - PubMed
    1. Mathew H., Farr O.M., Mantzoros C.S. Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism. 2016;65:73–80. doi: 10.1016/j.metabol.2015.10.019. - DOI - PMC - PubMed
    1. Henderson M., Van Hulst A., Von Oettingen J.E., Benedetti A., Paradis G., Von Oettingenn J.E. Normal weight metabolically unhealthy phenotype in youth: Do definitions matter? Pediatr. Diabetes. 2019;20:143–151. doi: 10.1111/pedi.12785. - DOI - PubMed